Article Information
History
- May 7, 2022.
Copyright
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. All rights reserved. No reuse allowed without permission.
Author Information
- Nahid Bhadelia1,2,3,*,
- Alex Olson1,
- Erika Smith4,
- Katherine Riefler1,
- Jacob Cabrejas1,
- Maria-Jose Ayuso4,
- Katherine Clarke4,
- Rachel R. Yuen4,
- Nina H. Lin1,
- Zachary J. Manickas-Hill5,
- Ian Rifkin6,7,
- Andreea Bujor8,
- Manish Sagar1,
- Anna C. Belkina4,9 and
- Jennifer E. Snyder-Cappione4,*
- 1Department of Medicine, Boston University School of Medicine, Boston, MA, USA
- 2Center for Emerging Infectious Diseases Policy & Research, Boston University School of Medicine, Boston, MA, USA
- 3National Emerging Infectious Diseases Laboratories (NEIDL), Boston University, Boston, MA, USA
- 4Department of Microbiology; Boston University School of Medicine, Boston, MA, USA
- 5Ragon Institute of MGH, MIT, and Harvard, Boston, MA, USA
- 6Renal Section, Department of Medicine, Boston University School of Medicine, Boston, MA, USA
- 7Renal Section, Department of Medicine, VA Boston Healthcare System, Boston, MA, USA
- 8Rheumatology, Arthritis and Autoimmune Diseases Center, Boston University Medical Center, Boston, MA, USA
- 9Flow Cytometry Core Facility, Boston University School of Medicine, Boston, MA, USA
- ↵*correspondence:
Nahid Bhadelia: nbhadeli{at}bu.edu; Jennifer Snyder-Cappione: cappione{at}bu.edu
Posted May 07, 2022.
Longitudinal analysis reveals elevation then sustained higher expression of autoantibodies for six months after SARS-CoV-2 infection
